The possible antioxidative effects of ketogenic diet by modifying brain klotho expression: a rat model study.

The ketogenic diet (KD) has long been used as an alternative nonpharmacological therapy to manage pharmacoresistant epilepsy. The anticonvulsant mechanisms of KD have yet to be fully elucidated. The present study explored whether a KD could exert antioxidative effects by altering brain Klotho (Kl) gene expression. Thirty male rats were divided into three groups: the normal diet (ND) group received standard rat chow; the calorie-restricted diet (CRD) group was maintained at 90% of the calculated energy need; and the KD group received a diet composed of 8% protein, 2% carbohydrates, and 90% fat (per calorie macronutrient). The levels of β-hydroxybutyrate (BHB) in the serum, gene expression in the brain, and Kl protein, malondialdehyde (MDA), and protein carbonyl (PC) levels in the serum and brain were evaluated by standard methods. The serum BHB levels in the KD group were significantly greater than those in the ND and CRD groups ( < 0.001). The Kl expression in the brain was significantly greater in the KD group than in the ND group ( = 0.028). The brain MDA levels in the KD group were significantly lower than those in the ND group ( = 0.006). Elevated BHB was positively correlated with brain expression (r = 0.668, < 0.001). The brain MDA levels were negatively correlated with brain expression (r = -0.531, = 0.003) and serum BHB levels (r = 0.472, = 0.020). KD might exert antioxidative effects by increasing BHB and upregulating in the brain. This could be considered a possible anticonvulsant mechanism of KD.